|
|
|
51-200 employees
View all
|
|
Pharmaceuticals
|
|
Grafenauweg 8, Zug, CH
|
|
Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. The company brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE.
The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.
|
Pharvaris Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Pharvaris email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Pharvaris customer service number call here +41-41-561-42-00. To contact Pharvaris customer service number in your country click here to find.
Berndt Modig is the CEO of Pharvaris. To contact Berndt Modig email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.